Listed by the USPTO as LUSI, ELLIS FOLLETT
Tech Center 1600 • Art Units: 1636 1672 1677 1678
This examiner grants 64% of resolved cases
LUSI, ELLIS FOLLETT is assigned to Tech Center 1600 and Art Unit 1636. The record covers 76 resolved cases and shows a 64.5% allowance rate. The median time to allowance is 1450 days, indicating extended pendency.
The interview lift is 54.1%, the most prominent measured prosecution signal in this profile relative to the allowance rate. The Regents of the University of California, Becton, Dickinson and Company, and UNIVERSITE PARIS CITE are the listed companies. The listed firms are BIRCH STEWART KOLASCH & BIRCH, LLP, HAUPTMAN HAM, LLP, and Knobbe, Martens, Olson & Bear, LLP. Practitioners may give interview preparation substantial strategic attention while planning for a long timeline.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18252605 | DEVELOPMENT OF A NOVEL ELISA-BASED POINT-OF-CARE ANTIGEN TEST FOR SARS-COV-2 | Non-Final OA | The Regents of the University of California |
| 18029606 | HIGH-THROUGHPUT METHOD FOR LP(A)-CHOLESTEROL QUANTITATION | Non-Final OA | The Regents of the University of California |
| 17389675 | REAGENT KIT, MEASUREMENT KIT, AND MEASUREMENT METHOD | Final Rejection | FUJIFILM Corporation |
| 17279025 | HIGH THROUGHPUT EPITOPE IDENTIFICATION AND T CELL RECEPTOR SPECIFICITY DETERMINATION USING LOADABLE DETECTION MOLECULES | Non-Final OA | 10x Genomics, Inc. |
| 18276885 | LATERAL FLOW TEST DEVICE | Non-Final OA | ams-OSRAM AG |
| 16932533 | MULTIPLEX LATERAL FLOW ASSAY FOR DIFFERENTIATING BACTERIAL INFECTIONS FROM VIRAL INFECTIONS | Final Rejection | Becton, Dickinson and Company |
| 16932532 | MULTIPLEX LATERAL FLOW ASSAY FOR DIFFERENTIATING BACTERIAL INFECTIONS FROM VIRAL INFECTIONS | Final Rejection | Becton, Dickinson and Company |
| 16890372 | LATERAL FLOW ASSAY AND METHODS FOR DETECTING HIGH CONCENTRATION ANALYTES | Final Rejection | Becton, Dickinson and Company |
| 18212168 | BIOHAZARD ANALYZER | Final Rejection | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 18248296 | COMPOSITIONS, SYSTEMS, AND METHODS RELATED TO A DUAL-AFFINITY RATIOMETRIC QUENCHING BIOASSAY | Final Rejection | North Carolina State University |
| 18281498 | COMPOSITE PARTICLE, METHOD FOR PRODUCING SAME AND SENSOR ELEMENT | Final Rejection | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18541875 | METHOD FOR IMMUNOSENSING ON A LIPID LAYER USING MAGNETIC TUNNEL JUNCTIONS | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18038653 | BIOMOLECULE STRUCTURE DETECTION PROBE, BIOMOLECULE STRUCTURE DETECTION KIT, AND METHOD FOR DETECTING BIOMOLECULE STRUCTURE | Final Rejection | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
| 18282396 | METHOD OF SELECTING CELLS | Non-Final OA | Lightcast Discovery Ltd |
| 18556559 | PANCREATIC CANCER DETECTION | Non-Final OA | RECCAN AB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.5% of resolved applications examined by Ellis Follett Lusi were allowed (76 resolved cases), compared with 37.5% across Art Unit 1636 over the last five years.
This examiner's interview lift is +54.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Ellis Follett Lusi took 1,450 days on average from filing to allowance.
Ellis Follett Lusi examines applications in Art Unit 1636 in Tech Center 1600 (Biotechnology & Pharmaceuticals).